obesity-995x60.png
FEATURED ARTICLES
When AI Agents Start Researching Trials On Behalf Of Patients, What Happens?
Right now, patients are using AI agents to find clinical trials. But soon enough, these AI tools will be doing it on their own and feeding patients the results. Recruitment expert Ross Jackson discusses this shift and what it will mean for sponsors.
-
![clinical-ecoa-GettyImages-2255935744]( "The Real Reason Sites Haven't Digitized")
The Real Reason Sites Haven't DigitizedReducing site burden doesn’t always require major change. Streamlining a single workflow can improve efficiency, strengthen compliance, and give site staff more time to focus on patients and trial execution.
-
![sitees-GettyImages-1058161052]( "The Site-Sponsor Digital Divide Is Slowing Clinical Trial Innovation")
The Site-Sponsor Digital Divide Is Slowing Clinical Trial InnovationClinical trial site digitization often stalls due to operational, cultural, and structural barriers. Site-centered workflows can overcome these, boosting efficiency, visibility, and execution.
-
![etmf-sites-GettyImages-1030071552]( "Why Site Training Still Slows Site Activation")
Why Site Training Still Slows Site ActivationEffective site training relies on clear, accessible, up-to-date materials that reflect real workflows — keeping sites aligned, compliant, and confident throughout the study lifecycle.
SERVICES AND PRODUCTS
With 150+ active sites and partner networks, Altasciences connects your clinical study to optimal locations and patients to reduce risk, accelerate enrollment, and stay on track.
For each prospective compound, we help you think through its clinical implications, safety parameters, and side effects to establish what will differentiate it in the current market landscape. With multiple drugs and limited funds, you need to choose the right products early. These best prospects will then generate cash and asset value to develop others.
In partnership with Health Advances, we’ll help you decide which investments will get you to an early proof of concept, which assets to advance and which to hold back, and which assets have synergies with others, whether in production, use, or market position. By the end of it all, you’ll have an effective, fully optimized portfolio.
Design, build, simulate, and analyze clinical studies in one connected system. Embedded intelligence supports the full lifecycle, from protocol development to closeout.
At DVCR, our Central Laboratory Services are built for multi-site studies, combining customizable kits, next-day results and real-time shipment monitoring to keep every site aligned and on schedule. Backed by dedicated client teams, a comprehensive Central Lab Manual and rapid-response testing, we deliver the flexibility and speed your studies require.
Digital health technologies have the potential to transform clinical trials, yet without careful planning and support, their implementation can increase site burden and jeopardize data quality.
Accelerate clinical trials with expert patient recruitment strategies delivering faster enrollment, lower dropout rates, and better outcomes.